‘Nobody is delighted with this news’ – HSE Drugs Group recommends not covering the cost of Friedreich’s ataxia drug
Irish IndependentProfessor Michael Barry said ‘real challenge is about balancing effectiveness of the drug versus the cost’
Irish Independent